Key stats
About GLOBAL X ETFS II ICAV CHINA BIOTECH UCITS ETF USD ACC
Expense ratio
0.68%
Home page
Inception date
Jan 18, 2022
The investment objective of the Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Biotech v2 USD Index NTR
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.54%
Health Technology99.51%
Bonds, Cash & Other0.46%
Cash0.49%
Corporate0.00%
Miscellaneous−0.03%
Stock breakdown by region
Asia97.40%
North America2.60%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history